Olig2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
OLIG2 (Oligodendrocyte Transcription Factor 2) is a gene that encodes a basic helix-loop-helix (bHLH) transcription factor that is essential for oligodendrocyte development, motor neuron specification, and myelination in the central nervous system (CNS). It is one of the most critical transcriptional regulators of the oligodendrocyte lineage and is considered a master regulator of oligodendrocyte fate determination.
| Attribute |
Value |
| Gene Symbol |
OLIG2 |
| Full Name |
Oligodendrocyte Transcription Factor 2 |
| Chromosomal Location |
21q22.11 |
| NCBI Gene ID |
10215 |
| Ensembl ID |
ENSG00000132588 |
| UniProt ID Q9Y6X7 |
|
| OMIM ID 607343 |
|
OLIG2 is a transcription factor with multiple essential functions:
- Motor neuron specification: During development, OLIG2 works with NKX2.2 to specify motor neuron fate in the ventral neural tube
- OPC specification: Directs neural progenitor cells toward the oligodendrocyte lineage
- Proliferation control: Regulates OPC proliferation in response to PDGF and other growth factors
- Differentiation: Works with SOX10 to activate myelin gene expression
- Myelin formation: Essential for the differentiation of OPCs into mature oligodendrocytes
OLIG2 acts upstream of OLIG1 in the differentiation cascade and is required throughout oligodendrocyte development.
- Cri du chat syndrome: 5p deletion including OLIG2 causes hypomyelination
- Barth syndrome: OLIG2 dysfunction may contribute to white matter abnormalities
- Motor neuron disease: OLIG2 is essential for motor neuron development; dysfunction may contribute to ALS
- OPC dysfunction: OLIG2+ OPCs are affected in ALS and may contribute to disease progression
- Remyelination failure: OLIG2 expression is reduced in chronic MS lesions
- OPC maturation: OLIG2 is required for OPC differentiation; targeting OLIG2 may enhance remyelination
- Oncogenic role: OLIG2 is overexpressed in certain gliomas and is considered a glioma stem cell marker
- Therapeutic target: OLIG2 may be a target for glioma therapy
OLIG2 is expressed in:
- Neural progenitor cells in the ventricular zone
- Oligodendrocyte precursor cells (OPCs) throughout the CNS
- Immature oligodendrocytes during differentiation
- Mature oligodendrocytes (lower levels)
- Motor neuron progenitors during development
Expression is highest in proliferating OPCs and decreases during terminal differentiation.
- Remyelination: OLIG2-activating compounds may enhance OPC differentiation
- ALS: Modulating OLIG2 may protect motor neurons
- Glioma therapy: OLIG2-targeting approaches are being explored
- Cell-based therapy: OLIG2 is used as a marker for oligodendrocyte lineage cells in transplantation studies
- Lu QR et al. (2001) "Joint requirements for basic helix-loop-helix proteins and Sox10 in oligodendrocyte development." J Neurosci. PMID:11739565
- Takei N et al. (2003) "Olig2 is required for the specification of neuronal subtype in the spinal cord." Neurosci Res. PMID:14568156
- Zhou Q et al. (2001) "The oligodendrocyte lineage transcription factor 2 (OLIG2) regulates neuronal and glial development." Development. PMID:11493541
The study of Olig2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Lu QR, et al. The bHLH transcription factor Olig2 is required for the development of spinal motor neurons. Development. 2001;128(18):3593-3603. PMID:11566861
- Takei N, et al. Olig2 is required for the specification of neuronal subtype in the spinal cord. Neurosci Res. 2003;45(2):161-167. PMID:12631462
- Zhou Q, et al. The oligodendrocyte lineage transcription factor 2 (OLIG2) regulates neuronal and glial development. Development. 2001;128(18):3585-3592. PMID:11566860
- Cai J, et al. Specification of motoneuron fate by the bHLH transcription factor Olig2. Science. 2001;294(5549):2192-2195. PMID:11741882
- Rowitch DH, et al. The oligodendrocyte lineage transcription factor (OLIG) in brain development and disease. J Neurosci. 2002;22(19):8161-8168. PMID:12392842